Atrys Health, S.A. (BME:ATRY)
Spain · Delayed Price · Currency is EUR 2.830
-0.040 (-1.39%)
Apr 7, 2026, 5:35 PM CET
Atrys Health Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 144.31 | 218.1 | 206.1 | 163.2 | 123.85 |
Other Revenue | 0.68 | - | - | - | - |
| 145 | 218.1 | 206.1 | 163.2 | 123.85 | |
Revenue Growth (YoY) | -33.52% | 5.82% | 26.28% | 31.77% | 266.34% |
Cost of Revenue | 115.51 | 162.17 | 148.96 | 116.26 | 89.67 |
Gross Profit | 29.48 | 55.92 | 57.15 | 46.95 | 34.19 |
Selling, General & Admin | - | 1.55 | 1.84 | 2.58 | 0.68 |
Other Operating Expenses | 18.85 | 23.41 | 27.21 | 29.15 | 16.75 |
Operating Expenses | 38.51 | 54 | 58.73 | 57.7 | 38.22 |
Operating Income | -9.02 | 1.92 | -1.58 | -10.75 | -4.03 |
Interest Expense | -19.02 | -23.48 | -33.05 | -14.53 | -11.03 |
Interest & Investment Income | 0.6 | 0.47 | 0.63 | 2.91 | 1.85 |
Currency Exchange Gain (Loss) | 0.07 | -1.19 | -0.04 | -0.42 | -1.32 |
Other Non Operating Income (Expenses) | 3.9 | 7.09 | 1.03 | -1.08 | 0.97 |
EBT Excluding Unusual Items | -23.48 | -15.2 | -33.01 | -23.88 | -13.57 |
Merger & Restructuring Charges | - | - | - | - | -11.3 |
Asset Writedown | -32.72 | -18.27 | -0.68 | -2.91 | -0.01 |
Pretax Income | -56.2 | -33.47 | -33.7 | -26.79 | -24.88 |
Income Tax Expense | -0.58 | -1.62 | -2.94 | -0.84 | -1.69 |
Earnings From Continuing Operations | -55.63 | -31.85 | -30.76 | -25.96 | -23.2 |
Earnings From Discontinued Operations | -44.92 | -0.16 | -15.14 | 2.55 | -0.05 |
Net Income to Company | -100.55 | -32.01 | -45.9 | -23.41 | -23.24 |
Minority Interest in Earnings | 0.25 | 0.23 | 0.31 | 0.26 | -0.01 |
Net Income | -100.3 | -31.77 | -45.59 | -23.15 | -23.26 |
Net Income to Common | -100.3 | -31.77 | -45.59 | -23.15 | -23.26 |
Shares Outstanding (Basic) | 42 | 76 | 76 | 68 | 50 |
Shares Outstanding (Diluted) | 42 | 76 | 76 | 68 | 50 |
Shares Change (YoY) | -44.75% | 0.16% | 11.15% | 35.64% | 77.58% |
EPS (Basic) | -2.39 | -0.42 | -0.60 | -0.34 | -0.46 |
EPS (Diluted) | -2.39 | -0.42 | -0.60 | -0.34 | -0.46 |
Free Cash Flow | -14.08 | -1.25 | -0.55 | -22.2 | 0.47 |
Free Cash Flow Per Share | -0.34 | -0.02 | -0.01 | -0.33 | 0.01 |
Gross Margin | 20.33% | 25.64% | 27.73% | 28.77% | 27.60% |
Operating Margin | -6.22% | 0.88% | -0.77% | -6.59% | -3.26% |
Profit Margin | -69.17% | -14.57% | -22.12% | -14.18% | -18.78% |
Free Cash Flow Margin | -9.71% | -0.57% | -0.27% | -13.60% | 0.38% |
EBITDA | 18.19 | 19.32 | 17.58 | 6.96 | 8.35 |
EBITDA Margin | 12.54% | 8.86% | 8.53% | 4.26% | 6.74% |
D&A For EBITDA | 27.21 | 17.4 | 19.16 | 17.71 | 12.39 |
EBIT | -9.02 | 1.92 | -1.58 | -10.75 | -4.03 |
EBIT Margin | -6.22% | 0.88% | -0.77% | -6.59% | -3.26% |
Revenue as Reported | - | 224.98 | 207 | 164.14 | 127.84 |
Advertising Expenses | - | 0.46 | 0.79 | 0.68 | 0.68 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.